| Product NDC: | 63717-325 |
| Proprietary Name: | Nasohist |
| Non Proprietary Name: | Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride |
| Active Ingredient(s): | 1; 3; 2 mg/mL; mg/mL; mg/mL & nbsp; Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63717-325 |
| Labeler Name: | Hawthorn Pharmaceuticals, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20110609 |
| Package NDC: | 63717-325-30 |
| Package Description: | 1 BOTTLE in 1 CARTON (63717-325-30) > 30 mL in 1 BOTTLE |
| NDC Code | 63717-325-30 |
| Proprietary Name | Nasohist |
| Package Description | 1 BOTTLE in 1 CARTON (63717-325-30) > 30 mL in 1 BOTTLE |
| Product NDC | 63717-325 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20110609 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Hawthorn Pharmaceuticals, Inc. |
| Substance Name | CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE |
| Strength Number | 1; 3; 2 |
| Strength Unit | mg/mL; mg/mL; mg/mL |
| Pharmaceutical Classes |